<DOC>
	<DOCNO>NCT02427516</DOCNO>
	<brief_summary>To estimate annualized total cost rate ( i.e . direct medical cost hospitalization , consultation , medication , test ) adequately control patient ( i.e . INR 2-3 TTRâ‰¥ 60 % ) diagnose non-valvular atrial fibrillation ( NVAF ) venous thromboembolism ( VTE ) , treat vitamin K antagonist ( VKA ) Spain .</brief_summary>
	<brief_title>Cost Monitoring Patients Treated With Vitamin K Antagonists Spain</brief_title>
	<detailed_description />
	<mesh_term>Vitamin K</mesh_term>
	<criteria>For information regard BMS clinical trial participation , please visit www.BMSStudyConnect.com Patients age 18 old study period Patients diagnosis NVAF VTE anytime medical record Patients least one year enrolment database prior index date Patients newly initiate VKA study period ( index date ) Patients diagnosis NVAF VTE anytime medical record</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2016</verification_date>
</DOC>